KANE BIOTECH INC (KNE.CA) Stock Cash Flow
TSX-V:KNE - TSX Venture Exchange - CA4838092084 - Common Stock - Currency: CAD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 5.64M | -5.27M | -3.82M | -4.85M | -3.85M | |||
| Depreciation Amortization | 203.20K | 238.60K | 263.40K | 188.00K | 78.10K | |||
| Change In Working Capital | -699.10K | 1.72M | 394.50K | 1.65M | -268.20K | |||
| Interest Paid | 920.10K | 258.00K | N/A | N/A | 0.00 | |||
| Other non cash items | -9.62M | 1.23M | 122.70K | 722.50K | 97.10K | |||
| OPERATING CASH FLOW | -4.48M | -2.08M | -3.04M | -2.29M | -3.94M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | 5.30K | -49.70K | -87.60K | -353.50K | -126.10K | |||
| Other Investing Activity | 10.22M | -66.40K | -20.00K | -20.00K | -40.00K | |||
| INVESTING CASH FLOW | 10.22M | -116.10K | -107.60K | -373.60K | -166.10K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -6.76M | 1.53M | 2.25M | 1.25M | 2.35M | |||
| Stock Issued/Repurchased | N/A | 415.80K | 973.70K | 1.12M | 695.50K | |||
| Other Financing Activity | -312.70K | 1.04M | -120.60K | 445.30K | 1.23M | |||
| FINANCING CASH FLOW | -6.82M | 2.98M | 3.10M | 2.81M | 4.28M | |||
| CHANGE IN CASH | -1.08M | 783.80K | -48.20K | 145.20K | 173.80K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -4.48M | -2.08M | -3.04M | -2.29M | -3.94M | |||
| Capital Expenditure | 5.30K | -49.70K | -87.60K | -353.50K | -126.10K | |||
| FREE CASH FLOW | -4.48M | -2.13M | -3.13M | -2.64M | -4.07M | |||
All data in CAD